{"entity":{"type":"insider","cik":"0001293973","url":"/insider/0001293973","json_url":"/insider/0001293973.json","name":"Ehrlich Christopher B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":14,"first":"2006-03-01","last":"2022-10-06","span_basis":"filed_date"},"name_variants":[{"name":"Ehrlich Christopher B","source":"filing","n_filings":14,"first_seen":"2006-03-01","last_seen":"2022-10-06"}],"transactions":[{"id":6926591,"accession":"0001209191-22-052933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052933","line_url":"/filing/0001209191-22-052933#line-1","is_derivative":false,"issuer_cik":"0001293973","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001293973","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":346.0,"shares_display":"346","price_per_share":0.57,"price_display":"0.57","price_state":"stated","total_value":197.22,"total_display":"197.22","total_whole":"197","shares_owned_after":35213.0,"shares_owned_after_display":"35,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-06","scope":"insider"},{"id":6330966,"accession":"0001209191-22-051313","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-051313","line_url":"/filing/0001209191-22-051313#line-1","is_derivative":false,"issuer_cik":"0001293973","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001293973","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18867.0,"shares_display":"18,867","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":10376.85,"total_display":"10,376.85","total_whole":"10,377","shares_owned_after":34867.0,"shares_owned_after_display":"34,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-27","scope":"insider"},{"id":6722983,"accession":"0001209191-22-011731","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-011731","line_url":"/filing/0001209191-22-011731#line-2","is_derivative":false,"issuer_cik":"0001293973","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001293973","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.3,"price_display":"4.30","price_state":"stated","total_value":4300.0,"total_display":"4,300.00","total_whole":"4,300","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-22","scope":"insider"},{"id":6722980,"accession":"0001209191-22-011731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011731","line_url":"/filing/0001209191-22-011731#line-1","is_derivative":false,"issuer_cik":"0001293973","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001293973","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.45,"price_display":"4.45","price_state":"stated","total_value":8900.0,"total_display":"8,900.00","total_whole":"8,900","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-14","filed_date":"2022-02-22","scope":"insider"},{"id":6143084,"accession":"0001209191-22-008529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008529","line_url":"/filing/0001209191-22-008529#line-2","is_derivative":false,"issuer_cik":"0001293973","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001293973","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":4750.0,"total_display":"4,750.00","total_whole":"4,750","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-10","scope":"insider"},{"id":6143081,"accession":"0001209191-22-008529","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-008529","line_url":"/filing/0001209191-22-008529#line-1","is_derivative":false,"issuer_cik":"0001293973","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001293973","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.92,"price_display":"4.92","price_state":"stated","total_value":4920.0,"total_display":"4,920.00","total_whole":"4,920","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-10","scope":"insider"},{"id":6367688,"accession":"0001209191-22-007349","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-007349","line_url":"/filing/0001209191-22-007349#line-2","is_derivative":false,"issuer_cik":"0001293973","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001293973","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-04","filed_date":"2022-02-07","scope":"insider"},{"id":6367685,"accession":"0001209191-22-007349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-007349","line_url":"/filing/0001209191-22-007349#line-1","is_derivative":false,"issuer_cik":"0001293973","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001293973","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":25750.0,"total_display":"25,750.00","total_whole":"25,750","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-03","filed_date":"2022-02-07","scope":"insider"},{"id":6325751,"accession":"0001209191-22-005721","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-005721","line_url":"/filing/0001209191-22-005721#line-1","is_derivative":false,"issuer_cik":"0001293973","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001293973","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.303,"price_display":"5.30","price_state":"stated","total_value":26515.0,"total_display":"26,515.00","total_whole":"26,515","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-27","filed_date":"2022-01-31","scope":"insider"},{"id":2162167,"accession":"0001209191-12-037464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-037464","line_url":"/filing/0001209191-12-037464#line-2","is_derivative":false,"issuer_cik":"0001198704","issuer_name":"TESARO, Inc.","issuer_ticker":"TSRO","issuer_name_source":null,"issuer_url":"/issuer/0001198704","owner_cik":null,"owner_name":"Holmes W Stephen; CLEVELAND BRUCE A; INTERWEST PARTNERS X LP; GIANOS PHILIP T; Pepper Douglas A; Kliman Gilbert H; Rosch Thomas L; CASH HARVEY B; Ehrlich Christopher B; Kjellson Nina S","owner_display_name":"Holmes W Stephen","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":444444.0,"shares_display":"444,444","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":3071701.0,"shares_owned_after_display":"3,071,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-03","filed_date":"2012-07-05","scope":"insider"},{"id":9132061,"accession":"0001181431-11-050247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-050247","line_url":"/filing/0001181431-11-050247#line-2","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Transcept Pharmaceuticals Inc","issuer_ticker":"TSPT","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":217228.0,"shares_display":"217,228","price_per_share":7.2418,"price_display":"7.24","price_state":"stated","total_value":1573121.7304,"total_display":"1,573,121.73","total_whole":"1,573,122","shares_owned_after":1983884.0,"shares_owned_after_display":"1,983,884","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-21","filed_date":"2011-09-22","scope":"insider"},{"id":9132060,"accession":"0001181431-11-050247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-050247","line_url":"/filing/0001181431-11-050247#line-1","is_derivative":false,"issuer_cik":"0001178711","issuer_name":"Transcept Pharmaceuticals Inc","issuer_ticker":"TSPT","issuer_name_source":null,"issuer_url":"/issuer/0001178711","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":514848.0,"shares_display":"514,848","price_per_share":6.585,"price_display":"6.58","price_state":"stated","total_value":3390274.08,"total_display":"3,390,274.08","total_whole":"3,390,274","shares_owned_after":1766656.0,"shares_owned_after_display":"1,766,656","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-20","filed_date":"2011-09-22","scope":"insider"},{"id":7567835,"accession":"0001181431-10-041125","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-10-041125","line_url":"/filing/0001181431-10-041125#line-3","is_derivative":false,"issuer_cik":"0001276600","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001276600","owner_cik":null,"owner_name":"InterWest Partners IX, LP; Grais Linda S; Pepper Douglas A; Ehrlich Christopher B; NASR KHALED","owner_display_name":"InterWest Partners IX, LP","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1227333.0,"shares_display":"1,227,333","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":6136665.0,"total_display":"6,136,665.00","total_whole":"6,136,665","shares_owned_after":3548643.0,"shares_owned_after_display":"3,548,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-06","filed_date":"2010-08-10","scope":"insider"},{"id":5965615,"accession":"0001209191-09-020955","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-020955","line_url":"/filing/0001209191-09-020955#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":941177.0,"shares_display":"941,177","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":8000004.5,"total_display":"8,000,004.50","total_whole":"8,000,005","shares_owned_after":941177.0,"shares_owned_after_display":"941,177","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-07","filed_date":"2009-04-08","scope":"insider"},{"id":7277400,"accession":"0001209191-07-071119","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-07-071119","line_url":"/filing/0001209191-07-071119","is_derivative":false,"issuer_cik":"0001123907","issuer_name":"ANESIVA, INC.","issuer_ticker":"ANSV","issuer_name_source":null,"issuer_url":"/issuer/0001123907","owner_cik":null,"owner_name":"HEDRICK W SCOTT; GIANOS PHILIP T; INTERWEST INVESTORS VIII L P; CASH HARVEY B; Kliman Gilbert H; Holmes W Stephen; INTERWEST INVESTORS Q VIII LP; Nash H Ronald; Ehrlich Christopher B; INTERWEST PARTNERS VIII LP","owner_display_name":"HEDRICK W SCOTT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1975309.0,"shares_display":"1,975,309","price_per_share":4.05,"price_display":"4.05","price_state":"stated","total_value":8000001.45,"total_display":"8,000,001.45","total_whole":"8,000,001","shares_owned_after":4627266.0,"shares_owned_after_display":"4,627,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-18","filed_date":"2007-12-20","scope":"insider","n_lines":3},{"id":7085755,"accession":"0001209191-07-065052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-065052","line_url":"/filing/0001209191-07-065052#line-1","is_derivative":false,"issuer_cik":"0001276600","issuer_name":"EnteroMedics Inc","issuer_ticker":"ETRM","issuer_name_source":null,"issuer_url":"/issuer/0001276600","owner_cik":null,"owner_name":"Grais Linda S; Westerlind Victor A; Nash H Ronald; InterWest Management Partners IX, LLC; Pepper Douglas A; Ehrlich Christopher B; NASR KHALED; Kjellson Nina S","owner_display_name":"Grais Linda S","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":1500000.0,"total_display":"1,500,000.00","total_whole":"1,500,000","shares_owned_after":187500.0,"shares_owned_after_display":"187,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-11-15","filed_date":"2007-11-19","scope":"insider"},{"id":4983283,"accession":"0001293973-06-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001293973-06-000002","line_url":"/filing/0001293973-06-000002#line-1","is_derivative":false,"issuer_cik":"0001138400","issuer_name":"BIOMIMETIC THERAPEUTICS, INC.","issuer_ticker":"BMTI","issuer_name_source":null,"issuer_url":"/issuer/0001138400","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":1250.0,"shares_owned_after_display":"1,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-15","filed_date":"2006-05-16","scope":"insider"},{"id":3864636,"accession":"0001293973-06-000001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001293973-06-000001","line_url":"/filing/0001293973-06-000001#line-4","is_derivative":false,"issuer_cik":"0001131517","issuer_name":"CORGENTECH INC","issuer_ticker":"CGTK","issuer_name_source":null,"issuer_url":"/issuer/0001131517","owner_cik":"0001293973","owner_name":"Ehrlich Christopher B","owner_display_name":"Ehrlich Christopher B","owner_url":"/insider/0001293973","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":9.02,"price_display":"9.02","price_state":"stated","total_value":19844.0,"total_display":"19,844.00","total_whole":"19,844","shares_owned_after":2237.0,"shares_owned_after_display":"2,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-02-28","filed_date":"2006-03-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001828522","name":"eFFECTOR Therapeutics, Inc.","url":"/issuer/0001828522","role":"Director","n_filings":6,"first_seen":"2022-01-31","last_seen":"2022-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001491576","name":"TESARO, Inc.","url":"/issuer/0001491576","role":"Ten percent owner","n_filings":1,"first_seen":"2012-07-05","last_seen":"2012-07-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001178711","name":"Transcept Pharmaceuticals Inc","url":"/issuer/0001178711","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2011-09-22","last_seen":"2011-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Other","n_filings":1,"first_seen":"2010-08-10","last_seen":"2010-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001138400","name":"BIOMIMETIC THERAPEUTICS, INC.","url":"/issuer/0001138400","role":"Director","n_filings":2,"first_seen":"2006-05-16","last_seen":"2009-04-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001131517","name":"ANESIVA, INC.","url":"/issuer/0001131517","role":"Ten percent owner","n_filings":2,"first_seen":"2006-03-01","last_seen":"2007-12-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001371217","name":"EnteroMedics Inc","url":"/issuer/0001371217","role":"Ten percent owner","n_filings":1,"first_seen":"2007-11-19","last_seen":"2007-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001293973","retrieved_at":"2026-08-27T03:03:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}